These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31484920)

  • 21. Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma.
    Arzt L; Halbwedl I; Gogg-Kamerer M; Popper HH
    Pathol Oncol Res; 2017 Jul; 23(3):595-605. PubMed ID: 27987139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of EphA2 stability by RNF5 limits its tumor-suppressive function in HER2-negative breast cancers.
    Li X; Wang F; Huang L; Yang M; Kuang E
    Cell Death Dis; 2023 Oct; 14(10):662. PubMed ID: 37816703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties.
    Li JY; Xiao T; Yi HM; Yi H; Feng J; Zhu JF; Huang W; Lu SS; Zhou YH; Li XH; Xiao ZQ
    Cancer Lett; 2019 Mar; 444():162-174. PubMed ID: 30583071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.
    Ikuta K; Yano S; Trung VT; Hanibuchi M; Goto H; Li Q; Wang W; Yamada T; Ogino H; Kakiuchi S; Uehara H; Sekido Y; Uenaka T; Nishioka Y; Sone S
    Clin Cancer Res; 2009 Dec; 15(23):7229-37. PubMed ID: 19934291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical role of the Ror-family of receptor tyrosine kinases in invasion and proliferation of malignant pleural mesothelioma cells.
    Saji T; Nishita M; Ogawa H; Doi T; Sakai Y; Maniwa Y; Minami Y
    Genes Cells; 2018 Jul; 23(7):606-613. PubMed ID: 29845703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
    Youngblood VM; Kim LC; Edwards DN; Hwang Y; Santapuram PR; Stirdivant SM; Lu P; Ye F; Brantley-Sieders DM; Chen J
    Cancer Res; 2016 Apr; 76(7):1825-36. PubMed ID: 26833123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.
    Teramoto K; Katoh H
    Cell Signal; 2019 Oct; 62():109329. PubMed ID: 31152846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Cbl-dependent EphA2 protein degradation is induced by ligand binding.
    Walker-Daniels J; Riese DJ; Kinch MS
    Mol Cancer Res; 2002 Nov; 1(1):79-87. PubMed ID: 12496371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM).
    Nasreen N; Mohammed KA; Lai Y; Antony VB
    Cancer Lett; 2007 Dec; 258(2):215-22. PubMed ID: 17949899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis.
    Fang WB; Brantley-Sieders DM; Parker MA; Reith AD; Chen J
    Oncogene; 2005 Nov; 24(53):7859-68. PubMed ID: 16103880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of EphA2 expression and mutant p53 in ovarian carcinoma.
    Merritt WM; Thaker PH; Landen CN; Deavers MT; Fletcher MS; Lin YG; Han LY; Kamat AA; Schmandt R; Gershenson DM; Kinch MS; Sood AK
    Cancer Biol Ther; 2006 Oct; 5(10):1357-60. PubMed ID: 16969087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
    Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
    Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolysis of EphA2 Converts It from a Tumor Suppressor to an Oncoprotein.
    Koshikawa N; Hoshino D; Taniguchi H; Minegishi T; Tomari T; Nam SO; Aoki M; Sueta T; Nakagawa T; Miyamoto S; Nabeshima K; Weaver AM; Seiki M
    Cancer Res; 2015 Aug; 75(16):3327-39. PubMed ID: 26130649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of small molecule agonists of EphA2 receptor.
    Petty A; Idippily N; Bobba V; Geldenhuys WJ; Zhong B; Su B; Wang B
    Eur J Med Chem; 2018 Jan; 143():1261-1276. PubMed ID: 29128116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.
    Rao M; Atay SM; Shukla V; Hong Y; Upham T; Ripley RT; Hong JA; Zhang M; Reardon E; Fetsch P; Miettinen M; Li X; Peer CJ; Sissung T; Figg WD; De Rienzo A; Bueno R; Schrump DS
    Clin Cancer Res; 2016 Mar; 22(5):1197-210. PubMed ID: 26459178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and functional crosstalk between extracellular Hsp90 and ephrin A1 signaling.
    Daoud A; Gopal U; Kaur J; Isaacs JS
    Oncotarget; 2017 Dec; 8(63):106807-106819. PubMed ID: 29290990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.
    Cheng YY; Wright CM; Kirschner MB; Williams M; Sarun KH; Sytnyk V; Leshchynska I; Edelman JJ; Vallely MP; McCaughan BC; Klebe S; van Zandwijk N; Lin RC; Reid G
    Mol Cancer; 2016 Jun; 15(1):44. PubMed ID: 27245839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
    Kanteti R; Mirzapoiazova T; Riehm JJ; Dhanasingh I; Mambetsariev B; Wang J; Kulkarni P; Kaushik G; Seshacharyulu P; Ponnusamy MP; Kindler HL; Nasser MW; Batra SK; Salgia R
    Cancer Biol Ther; 2018 Apr; 19(4):316-327. PubMed ID: 29303405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphoproteomic profiling of NSCLC cells reveals that ephrin B3 regulates pro-survival signaling through Akt1-mediated phosphorylation of the EphA2 receptor.
    Ståhl S; Branca RM; Efazat G; Ruzzene M; Zhivotovsky B; Lewensohn R; Viktorsson K; Lehtiö J
    J Proteome Res; 2011 May; 10(5):2566-78. PubMed ID: 21413766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
    Brantley-Sieders DM; Caughron J; Hicks D; Pozzi A; Ruiz JC; Chen J
    J Cell Sci; 2004 Apr; 117(Pt 10):2037-49. PubMed ID: 15054110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.